Stem Cell Theranostics is a precision medicine-focused biotechnology company developing genetically-targeted therapies for heart failure.
The Impact of Heart Failure
Heart failure is a serious and growing medical concern. Genetic heart failure effects 1 in 500 people and touches the lives of nearly everyone. The global burden of heart failure on healthcare is a staggering $110B. Still there are no approved drugs that treat the underlying causes of disease. Additionally, drug-induced heart failure – which has a genetic basis – is responsible for 28% of drug withdrawals.
There is critical need for translational preclinical models that address specific pathophysiology based on a patient’s genetic profile. Models that can be used to develop genetically-targeted therapies and assess cardiotoxicity. Discover more.